Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease.
Czartoryska
B
B
Institute of Psychiatry and Neurology, Department of Genetics, Warsaw, Poland. czartor@ipin.edu.pl
Tylki-Szymańska
A
A
Lugowska
A
A
D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004334:Drug Administration Schedule; D005260:Female; D005776:Gaucher Disease / Q000097:blood / Q000188:drug therapy* / Q000201:enzymology*; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000627:therapeutic use*; D006596:Hexosaminidases / Q000097:blood*; D006801:Humans; D008297:Male; D013997:Time Factors
C070292:alglucerase; D006596:Hexosaminidases; C086400:chitotriosidase; D005962:Glucosylceramidase